AU2597599A - The use of hiv-1 integrase in screening hiv-1 drug candidates - Google Patents

The use of hiv-1 integrase in screening hiv-1 drug candidates

Info

Publication number
AU2597599A
AU2597599A AU25975/99A AU2597599A AU2597599A AU 2597599 A AU2597599 A AU 2597599A AU 25975/99 A AU25975/99 A AU 25975/99A AU 2597599 A AU2597599 A AU 2597599A AU 2597599 A AU2597599 A AU 2597599A
Authority
AU
Australia
Prior art keywords
hiv
integrase
screening
drug candidates
candidates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25975/99A
Inventor
John C. Kappes
Xiaoyun Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UAB Research Foundation
Original Assignee
UAB Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UAB Research Foundation filed Critical UAB Research Foundation
Publication of AU2597599A publication Critical patent/AU2597599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU25975/99A 1998-02-10 1999-02-10 The use of hiv-1 integrase in screening hiv-1 drug candidates Abandoned AU2597599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7427498P 1998-02-10 1998-02-10
US60074274 1998-02-10
PCT/US1999/002912 WO1999040227A1 (en) 1998-02-10 1999-02-10 The use of hiv-1 integrase in screening hiv-1 drug candidates

Publications (1)

Publication Number Publication Date
AU2597599A true AU2597599A (en) 1999-08-23

Family

ID=22118705

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25975/99A Abandoned AU2597599A (en) 1998-02-10 1999-02-10 The use of hiv-1 integrase in screening hiv-1 drug candidates

Country Status (3)

Country Link
EP (1) EP1053358A4 (en)
AU (1) AU2597599A (en)
WO (1) WO1999040227A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7206699B2 (en) 2000-04-18 2007-04-17 Virco N.V. Methods for measuring therapy resistance
AU2001270098A1 (en) * 2000-06-22 2002-01-02 San Diego State University Foundation Recombination modulators and methods for their production and use
WO2002063029A1 (en) * 2001-02-02 2002-08-15 Iconix Pharmaceuticals, Inc. Alteration of phenotype due to heterologous genes
EP1285971B1 (en) * 2001-08-08 2007-10-10 Tibotec Pharmaceuticals Ltd. Methods for the phenotypic and genotypic assessment of the drug sensitivity of HIV integrase variants
US6958211B2 (en) 2001-08-08 2005-10-25 Tibotech Bvba Methods of assessing HIV integrase inhibitor therapy
US7927790B2 (en) * 2005-05-24 2011-04-19 City Of Hope Suppression of HIV-1 replication via inhibition of human flap endonuclease-1-mediated HIV-1 central DNA flap processing
CN111471717B (en) * 2020-04-17 2021-05-04 复百澳（苏州）生物科技有限公司 Preparation method of pseudovirus for 2019 new coronavirus nucleic acid detection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256534A (en) * 1991-08-09 1993-10-26 The United States Of America As Represented By The Department Of Health And Human Services CD4+, latently HIV-1-infected hematopoietic progenitor cells
DE69637677D1 (en) * 1995-04-14 2008-10-23 Univ Alabama Res Found TRANSFER SYSTEM BASED ON A FUSION PROTEIN AND ITS APPLICATIONS.
WO1999049891A1 (en) * 1998-03-30 1999-10-07 Thomas Jefferson University Compositions and methods for providing a vpr-binding protein to a virion

Also Published As

Publication number Publication date
WO1999040227A1 (en) 1999-08-12
EP1053358A1 (en) 2000-11-22
EP1053358A4 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
ZA985618B (en) Sulfonamide compounds and pharmaceutical use thereof
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
IL202633A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
AU5387898A (en) Pharmaceutical agents
AU2270101A (en) Pharmaceutical kit
AU3118200A (en) Hiv integrase inhibitors
AU2415299A (en) Substituted benzenesulfonamide derivatives and their pharmaceutical use
AU6616400A (en) Hiv integrase inhibitors
AU4607301A (en) Ring oscillator
AU1409100A (en) Drugs
EP1086091A4 (en) Hiv integrase inhibitors
AU3366899A (en) Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors
AU6565100A (en) Liquid pharmaceutical composition based on paracetamol
AU8009900A (en) Hiv integrase inhibitors
AU2841801A (en) Triazolotriazinones and the use thereof
AU2597599A (en) The use of hiv-1 integrase in screening hiv-1 drug candidates
IL143439A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
AU5082200A (en) Metrological instrument
AU1688099A (en) Pharmaceutical preparation
AU5416898A (en) Cisplatinum comprising pharmaceutical
AU6271098A (en) Hiv integrase inhibitors
AU5483600A (en) Pharmaceutical materials and methods for their preparation and use
EP1037963A4 (en) X-ray crystal comprising hiv-1 gp120
AU2001264900A1 (en) Pharmaceutical use of fibulin-1

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase